Evidence map›Paper›PMID 28255535›Full record

ArticleFEBS open bio2016

Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation.

Hongyong Zhang, Yufeng Wang, Zhikui Liu, Bowen Yao, Changwei Dou, Meng Xu, Qing Li, Yuli Jia, Shengli Wu, Kangsheng Tu and 1 more

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in FEBS open bio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. PHF19 inhibition as a therapeutic target in multiple myeloma.Current research in translational medicine · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Hongyong ZhangDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Yufeng WangDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Zhikui LiuDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Bowen YaoDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Changwei DouDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Meng XuDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Qing LiDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Yuli JiaDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Shengli WuDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Kangsheng TuDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
Qingguang LiuDepartment of Hepatobiliary Surgery The First Affiliated Hospital of Xi'an Jiaotong University China.
First Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphocyte-specific protein 1 (LSP1) has been reported to regulate cell biology in several human cancers including lymphoma and breast cancer. However, the functions of LSP1 in human hepatocellular carcinoma (HCC) are still unknown. In this study, we found that LSP1 expression was downregulated in HCC tissues and cell lines, and lower LSP1 expression was correlated with poor clinicopathological features including large tumor size, high Edmondson-Steiner grading and advanced tumor-node-metastasis (TNM) stage. Additionally, we demonstrated that patients with high LSP1 expression had significantly better overall survival and disease-free survival. Moreover, LSP1 was found to be an independent factor for predicting the prognosis of HCC patients.

Indexed as

apoptosisextracellular regulated protein kinase pathwayhepatocellular carcinomalymphocyte‐specific protein 1proliferation

Identifiers

PMID28255535
PMCPMC5324767
OpenAlexW2529627658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.